News Archive |
2009December - New financingPromimic has received new funds of three million kronor. The investment comes from current owners and three new investors. The company has through these financings gained a stronger shareholder structure. New investors are Sätila Medtech and two business angels. - We are pleased to see that both our current owners and new investors are willing to support us in our progress and development of the company. 2010 has started off in a very positive way and we are now excited to face the challenges ahead, says Ulf Brogren, CEO Promimic. November - NASSPromimic visited the NASS exhibition in San Fransisco, 10-14 november. July - OMTEC exhibition- Great thanks to everybody visiting our booth at the OMTEC exhibition in Rosemont Chicago, making our participation at the fair a big success. We had a fantastic show, with lots of traffic around our booth and we are very happy to get the confirmation that our technology is unique and interesting to the players on the international market, says CEO Ulf Brogren. If you have any questions or want more information about Promimic and our technology, don´t hesitate to contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it March - IDSPromimic visited the IDS exhibition in Cologne. 2008September – Biotech forumPromimic attended the Biotech forum fair at Bella Center, Copenhagen. For more information see; http://www.biotechforum.org/ May - ISO CertificatePromimic has a management system that fulfils the requirements of SS-EN ISO 13485:2003 with respect to development, production and sales of synthetic bone material for implant applications. - This strengthens our credibility as a reliable partner/supplier to the global implant companies. Ulf Brogren, CEO Promimic. May – 1.6 million Swedish kronor for the development of synthetic bone!A total of 407 companies applied, only 21 received VINNOVA: s grant to realize R&D projects. Promimic was one of the few chosen. - As a young company, this grant gives us the opportunity to practice a more extensive development of new products. This would not have been possible without the grant. These products will be the base of a long-term growth for Promimic. To be one of the few companies that receives this grant is an acknowledgment that our technique is unique and has great potential. Furthermore, it shows that we have a clear and well-worked out plan for reaching the market with our new technology, says Ulf Brogren, CEO Promimic. 2007December – New share issueThe capital fund Karolinska Development III has invested in Promimic. New capital and solid owners has been prerequisites for further expansion. - We are very pleased that Promimic chose us as an investor in the company. Promimic has a very exciting technology that can be applied onto various product areas and can bring about higher tolerance and better integration of implants and implant materials. Gösta Sjöholm, Investment manager at Karolinska Development III AB. January - Promimics first orderToday, Promimic has entered the commercial market with an order from Q-Sense. Last December, Q-Sense introduced their new sensor crystal with Promimic´s hydroxyapatite surface modification. - We are thrilled to be able to provide our first customer with the hydroxyapatite surface. It gives us strength as a company and we will get good market authentication through this deal. Ulf Brogren, CEO Promimic. 2006March – New share issuePromimic has reinforced the funds with one million SEK. Private investors and companies such as Innovationbron Väst StartUp AB and Chalmers Innovation have invested in Promimic. 2005November – Swedish patent registeredA Swedish patent has been granted for Promimics unique method for surface modification and the production of Hydroxyapatite in the same structure and shape as it exist naturally in the hard structures of human bone and teeth. April - Promimic wins first award in a national innovation contestThe companies VINNOVA and Nutek have financed 20 technology based companies trough the competition Vinn Nu. Promimic received 300 000 SEK to commercialize the innovation. 2004October – Chalmers Innovation supports projectMartin Andersson and Per Kjellin start a project to commercialize their innovation and are accepted as an incubation project in Chalmers Innovation. The foundation, Chalmers Innovation, invests 300 000 SEK in the project. February – Scientific cooperationPreliminary scientific cooperation has begun between Promimic and Professor Ann Wennerberg at the Department of Odontology, Sahlgrenska Academy, Gothenburg. The purpose is to evaluate the effect of Promimics innovation through scientific studies. 2003November – Innovation grantVästragötalandsregionen gives its innovation grant to Martin Andersson and Per Kjellin, allowing them to continue to develop their business concept. June – Martin Andersson and Per Kjellin receives innovation grantMartin Andersson and Per Kjellin receive a Chalmers Innovations grant for innovations. This will help the two scientists develop their innovation concerning the production of artificial bone and teeth.
|
